Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.5650
+0.0850 (5.74%)
NASDAQ · Last Trade: Nov 4th, 8:53 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors